AbbVie, following in footsteps of Lilly and Takeda, pays Anima $42M to go after undruggable...

cafead

Administrator
Staff member
  • cafead   Jan 10, 2023 at 11:32: AM
via AbbVie has joined Anima Biotech’s star-studded roster of partners, paying $42 million upfront to work with the biotech on small molecule mRNA drugs against three “undruggable” targets in oncology and immunology.

article source